According to Korro Bio's latest financial reports the company has A$0.17 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | A$0.20 B | -16.87% |
2023-12-31 | A$0.24 B | 200.38% |
2022-12-31 | A$81.18 M | -50.34% |
2021-12-31 | A$0.16 B |